Projects funded by the NCN
Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for next generation osteosarcoma treatments?
2022/45/N/NZ1/02699
Keywords:
cancer PD-1 receptor immune checkpoint inhibitors immunotherapy osteosarcoma canine model rare human diseases large animal models
Descriptors:
- NZ3_1: Cell biology
- NZ1_1: Molecular biology
- NZ4_3: Comparative physiology
Panel:
NZ1 - Molecular biology, structural biology, biotechnology: molecular biology, structural biology, biotechnology
Host institution :
Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2023-02-03
Project end date (Y-m-d): 2026-02-02
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.